SKNJCT-003 Doxorubicin containing Microneedle Array (D-MNA) clinical development program to non-invasively treat BCC aligns with national priorities of public health impact, unmet medical need, access ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback